TTBIO Corp. (6493) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TTBIO Corp. (6493:TWSE), powered by AI.

Current Price
$26.00
Sector
Healthcare
What is the TTBIO Corp. stock price forecast?

TTBIO Corp. is currently trading at $26.00. View real-time AI analysis on Alpha Lenz.

What is TTBIO Corp. insider trading activity?

View the latest insider trading data for TTBIO Corp. on Alpha Lenz.

What is TTBIO Corp.'s P/E ratio?

View TTBIO Corp.'s valuation metrics on Alpha Lenz.

TTBIO Corp.

TWSE · 6493
NT$26.00+0.15(+0.58%)
Ask about TTBIO Corp.'s future dividend policy...
Alpha Chat Insight

TTBIO Corp.'s ROE is -6.5%. Explore profitability and growth together.

Ask for details

Company Overview

TTBIO Corp. is a healthcare technology company specializing in the design, manufacture, and servicing of medical devices, with a particular focus on dental equipment. The company’s primary offerings include high and low-speed dental handpieces, dental spare parts, service rotors, maintenance units, and electric handpiece systems. These products are utilized extensively in dental care procedures such as tooth repair, shaping, polishing, filling adjustments, porcelain customization, and root canal treatments. In addition to dental-specific devices, TTBIO Corp. produces precision machined components that serve industries beyond healthcare, such as automotive, aerospace, computer hardware, and security systems. Founded in 2012 and headquartered in Taichung, Taiwan, TTBIO Corp. occupies a significant niche within the medical instruments and supplies sector, providing both standard and custom solutions for practitioners and businesses in Taiwan and international markets. The company’s role in the market is underpinned by its emphasis on quality and reliability in precision engineering, supporting a diverse range of industrial clients and expanding access to specialized medical technology.

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees118

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$398.88MRevenue
0.00Shares Out
118Employees

Margins

17.63%Gross
5.22%EBITDA
-5.21%Operating
-5.30%Pre-Tax
-5.34%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-1.62%Rev 3Yr
17.39%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-3.46%ROA
-6.53%ROE
-2.55%ROIC

Financial Health

NT$53.75MCash & Cash Equivalents
NT$211.31MNet Debt
74.17%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

TTBIO Corp. (ticker: 6493) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 118 employees.

The current price is 26 with a P/E ratio of -x and P/B of -x.

ROE is -6.53% and operating margin is -5.21%. Annual revenue is $399M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
TTBIO Corp. (6493) Stock Forecast 2026 $26.00 — Price, Financials & Analyst Targets | Alpha Lenz